Monte Rosa Therapeutics, Inc. - GLUE
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | President & CEO | S | D | 8,000.0 | 17.6406 | 141,124.8 | 605,471.0 | View | |
| Apr 10, 2026 | Chief Business & Legal Officer | S | D | 5,845.0 | 17.6925 | 103,412.66 | 55,000.0 | View | |
| Apr 07, 2026 | Principal Accounting Officer | A | A | 19,500.0 | 0.0 | 0.0 | 19,500.0 | View | |
| Apr 07, 2026 | Principal Accounting Officer | A | A | 4,300.0 | — | — | 25,904.0 | View | |
| Mar 05, 2026 | Principal Accounting Officer | S | D | 139.0 | 17.96 | 2,496.44 | 22,554.0 | View | |
| Mar 04, 2026 | President & CEO | S | D | 5,466.0 | 17.9243 | 97,974.22 | 613,471.0 | View | |
| Mar 02, 2026 | Principal Accounting Officer | M | D | 536.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 02, 2026 | Principal Accounting Officer | M | D | 25,164.0 | 0.0 | 0.0 | 536.0 | View | |
| Mar 02, 2026 | Principal Accounting Officer | S | D | 536.0 | 17.5 | 9,380.0 | 22,693.0 | View | |
| Mar 02, 2026 | Principal Accounting Officer | M | A | 536.0 | 13.41 | 7,187.76 | 23,229.0 | View | |
| Mar 02, 2026 | Principal Accounting Officer | S | D | 25,164.0 | 18.1015 | 455,506.15 | 22,693.0 | View | |
| Mar 02, 2026 | Principal Accounting Officer | M | A | 25,164.0 | 13.41 | 337,449.24 | 47,857.0 | View | |
| Feb 24, 2026 | Chief Medical Officer | S | D | 9,189.0 | 19.4973 | 179,160.69 | 65,837.0 | View | |
| Jan 09, 2026 | President & CEO | S | D | 309.0 | 24.5736 | 7,593.24 | 618,937.0 | View | |
| Jan 09, 2026 | President & CEO | S | D | 1,450.0 | 23.8762 | 34,620.49 | 619,246.0 | View | |
| Jan 09, 2026 | President & CEO | S | D | 3,707.0 | 23.2422 | 86,158.84 | 620,696.0 | View | |
| Jan 05, 2026 | Chief Medical Officer | A | A | 139,000.0 | 0.0 | 0.0 | 139,000.0 | View | |
| Jan 05, 2026 | Chief Medical Officer | S | D | 3,155.0 | 15.17 | 47,861.35 | 75,026.0 | View | |
| Jan 05, 2026 | Chief Medical Officer | A | A | 31,000.0 | — | — | 78,181.0 | View | |
| Jan 05, 2026 | Chief Business & Legal Officer | A | A | 126,000.0 | 0.0 | 0.0 | 126,000.0 | View | |
| Jan 05, 2026 | Chief Business & Legal Officer | S | D | 3,155.0 | 15.17 | 47,861.35 | 60,845.0 | View | |
| Jan 05, 2026 | Chief Business & Legal Officer | A | A | 28,000.0 | — | — | 64,000.0 | View | |
| Jan 05, 2026 | Chief Operating Officer | A | A | 158,000.0 | 0.0 | 0.0 | 158,000.0 | View | |
| Jan 05, 2026 | Chief Operating Officer | S | D | 2,629.0 | 15.17 | 39,881.93 | 62,371.0 | View | |
| Jan 05, 2026 | Chief Operating Officer | A | A | 35,000.0 | — | — | 65,000.0 | View | |
| Jan 05, 2026 | Principal Accounting Officer | S | D | 1,039.0 | 15.17 | 15,761.63 | 22,693.0 | View | |
| Jan 05, 2026 | President & CEO | A | A | 406,000.0 | 0.0 | 0.0 | 406,000.0 | View | |
| Jan 05, 2026 | President & CEO | S | D | 10,135.0 | 15.17 | 153,747.95 | 624,403.0 | View | |
| Jan 05, 2026 | President & CEO | A | A | 90,000.0 | — | — | 634,538.0 | View | |
| Jan 05, 2026 | Chief Scientific Officer | A | A | 158,000.0 | 0.0 | 0.0 | 158,000.0 | View | |
| Jan 05, 2026 | Chief Scientific Officer | S | D | 3,155.0 | 15.17 | 47,861.35 | 67,845.0 | View | |
| Jan 05, 2026 | Chief Scientific Officer | A | A | 35,000.0 | — | — | 71,000.0 | View |